Financial Daily from THE HINDU group of publications
Wednesday, Feb 15, 2006


Group Sites

Marketing - New Products & Services

Bird flu: SRL Ranbaxy puts out diagnostic test

Our Bureau

New Delhi , Feb. 14

SRL Ranbaxy has launched the RT-PCR diagnostic test for bird flu disease.

This test can be effectively employed for mass screening and gives accurate results in one day, faster than the time taken by other tests.

Outbreak of bird flu in migratory birds in China, Tibet, Mongolia, Russia and recently Turkey has raised fears that the virus responsible could spread to India and other countries.

These tests will cost between Rs 1,200 and Rs 2,500 and would be available nationally.

An official spokesperson said, "India has not reported any case of bird flu in humans or birds. But we must be prepared adequately if we are to contain the disease before it gets out of control. This test will be available across our 550 centres in over 350 cities through our network."

Also, during the SARS outbreak in 2003, SRL Ranbaxy offered tests.

More Stories on : New Products & Services | Pharmaceuticals | Poultry

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
GRT Regency to expand to smaller towns in South

Miditech to launch new reality show formats
SSI plans to set up 18 multiplex screens
Suzuki chief ferries Japanese dealers on `incentive' trip to India
A jingle called `single brand'
Retail sector smells fragrant for luxury maker YSL
Himalaya to focus more on service
TCS Textile subsidiary launches `Madras Yarn'
E-biz sites court Netizens on V-Day; traffic trebles
A buoyant IT hardware market
Bird flu: SRL Ranbaxy puts out diagnostic test
Samsung unveils range of LCD monitors
eSys introduces mini PCs
Tally launches version with 10 Indian language interfaces

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line